Read the Registration Document - Guerbet

In 2005, the Group acquired for ¥593 million on a present value basis from the previous distributor ofImagenil (Oxilan) in Japan various intangible assets destined to maintain the commercial relations existingwith the Japanese customer base when the distribution was transferred to Terumo. At 31 December 2010,the net carrying value after amortisation had been fully written down. These intangible assets were writtenoff in 2012.Business goodwill was acquired from former Group distributors when commercial subsidiaries were openedin various countries. This goodwill was amortised over 20 years until the IFRS transition date of 31December 2003. Because the useful life of this goodwill is currently considered indefinite, as of 1 January2004 it was no longer amortised.Software is amortised over its useful life that is generally approximately three years.Estimates of recoverable values of cash generating units including goodwill or indefinite life intangibleassets representing material amounts:The cash generating units were as follows:Cash generating units Goodwill and intangible assets Net carrying valueTrademarks (Magnescope) 1,325JapanCommercial relations -Marketing authorisations 6,114Patents 1,745GermanyTrademarks (Barium) 7,476Goodwill 990South Korea Goodwill 4,252Italy Goodwill 3,796Medex Patent 2,079At 31 December 2012, impairment tests were conducted on the basis of discounted cash flows determinedaccording to the medium-term plan or more detailed data. This MTP covers the years from 2013 to 2017.A discount rate of 4.85% was applied to all assets other than of Japan (3.70%).The calculation of value in use does not incorporate the notion of a terminal value. For each of these CGUs,the present value of future cash flows exceeds the net carrying value. In respect to sensitivity, a 1 pointvariance in interest rates would not have resulted in the recognition of an impairment charge.93